The present invention discloses a polymer-metal compound composite ink, a preparation method and application thereof. The composite ink comprises: at least one polymer; at least one metal compound material, the metal compound material being selected from polyoxometalate compounds and nanocrystalline metal oxides; at least one solvent which is used for forming a disperse system in the form of a uniform fluid together with the remaining components in the composite ink. The present invention also discloses a method for preparing the composite ink. The composite ink of the present invention is easily available in raw material, easy to prepare and low in cost, and can be manufactured into a composite thin film by spin-coating, printing or in other ways. The composite thin film, as an electrode modification layer, can be applied to photoelectric devices such as solar cells or light-emitting diodes, so as to improve the contact performance between an electrode and an organic active layer and thus enhance the performance and yield of photoelectric devices.

The present invention relates to a novel provided gallium arsenide substrates as well as the use thereof. The gallium arsenide substrates provided according to the invention exhibit a so far not obtained surface quality, in particular a homogeneity of surface properties, which is detectable by means of optical surface analyzers, by way of example by means of ellipsometric lateral substrate mapping for optical contact-free quantitative characterization.

A gallium arsenide substrate which exhibits at least one surface having a surface oxide layer comprising gallium and arsenic oxides and which exhibits at least one surface having, according to an ellipsometric lateral substrate mapping with an optical surface analyzer, based on a substrate diameter of 150 mm as reference, a defect number of <6000 and/or a total defect area of less than 2 cm.sup.2, wherein a defect is defined as a continuous area of greater than 1000 μm.sup.2 having a deviation from the average measurement signal in elipsometric lateral substrate mapping with an optical surface analyzer of at least ±0.05%.

There is provided a method for the removal of arsenic from an arsenical bearing sulfides ore, comprising a thermal treatment of arsenical sulfide in the presence of sulfur dioxide, yielding a calcine and a sublimate, the sublimate containing arsenious oxide. The method allows recovering metallic value from an arsenic-bearing metallic sulfides ore, by recovery of the calcine comprising the metallic value of the ore.

The present invention relates to a pharmaceutical composition for preventing or treating liver cancer and a method for producing same, the composition comprising tetraarsenic hexoxide in which the content of tetraarsenic hexoxide crystalline polymorph a (As.sub.4O.sub.6-a) is 99% or more. The composition of the present invention exhibits an excellent cancer cell proliferation inhibition effect and thus can be useful as an anticancer drug.

The present invention relates to a pharmaceutical composition for preventing or treating liver cancer and a method for producing same, the composition comprising tetraarsenic hexoxide in which the content of tetraarsenic hexoxide crystalline polymorph a (As.sub.4O.sub.6-a) is 99% or more. The composition of the present invention exhibits an excellent cancer cell proliferation inhibition effect and thus can be useful as an anticancer drug.

The present invention relates to a pharmaceutical composition for preventing or treating breast cancer which includes tetraarsenic hexoxide in which a crystalline polymorph a(As.sub.4O.sub.6-a), of tetraarsenic hexoxide is 99% or higher, and to a method for producing the same. The composition of the present invention exhibits excellent effects of inhibiting the proliferation and metastasis of cancer cells, and thus can be usefully used as an anticancer agent.

The present invention relates to a pharmaceutical composition for preventing or treating breast cancer which includes tetraarsenic hexoxide in which a crystalline polymorph a(As.sub.4O.sub.6-a), of tetraarsenic hexoxide is 99% or higher, and to a method for producing the same. The composition of the present invention exhibits excellent effects of inhibiting the proliferation and metastasis of cancer cells, and thus can be usefully used as an anticancer agent.

The present invention relates to a novel process for producing a surface-treated gallium arsenide substrate as well as novel provided gallium arsenide substrates as such as well as the use thereof. The improvement of the process according to the invention is based on a particular final surface treatment with an oxidation treatment of at least one surface of the gallium arsenide substrate in dry condition by means of UV radiation and/or ozone gas, a contacting of the at least one surface of the gallium arsenide substrate with at least one liquid medium and a Marangoni drying of the gallium arsenide substrate. The gallium arsenide substrates provided according to the invention exhibit a so far not obtained surface quality, in particular a homogeneity of surface properties, which is detectable by means of optical surface analyzers, specifically by means of ellipsometric lateral substrate mapping for the optical contact-free quantitative characterization.

There is provided a method for the removal of arsenic from an arsenical bearing sulfides ore, comprising a thermal treatment of arsenical sulfide in the presence of sulfur dioxide, yielding a calcine and a sublimate, the sublimate containing arsenious oxide. The method allows recovering metallic value from an arsenic-bearing metallic sulfides ore, by recovery of the calcine comprising the metallic value of the ore.